Reference:

Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)



Reference Alert Title Originated ByIssue DateStatus
CEM/CMO/2021/017 Casirivimab and imdevimab for patients hospitalised due to COVID-19 CMO Messaging 17-Sep-2021 Issued
SDA/2021/011 Becton Dickinson blood specimen collection - supply disruption (update) DHSC & NHS England and Improvement: Supply disruption alert 16-Sep-2021 Issued
CEM/CMO/2021/016 Interleukin-6 inhibitors (tocilzumab or sarilumab) for patients hospitalised due to COVID-19 CMO Messaging 12-Sep-2021 Issued
CEM/CMO/2021/015 COVID-19 Therapeutic Alert: Continuous positive airway pressure (CPAP) in patients hospitalised due ... CMO Messaging 02-Sep-2021 Issued
SDA/2021/010 Becton Dickinson blood specimen collection - supply disruption DHSC & NHS England and Improvement: Supply disruption alert 26-Aug-2021 Issued
NatPSA/2021/009/NHSPS Infection risk when using FFP3 respirators with valves or Powered Air Purifying Respirators (PAPRs) ... National Patient Safety Alert - NHS England & NHS Improvement 25-Aug-2021 Issued
NatPSA/2021/008/NHSPS Elimination of bottles of liquefied phenol 80% National Patient Safety Alert - NHS England & NHS Improvement 25-Aug-2021 Issued
NatPSA/2021/007/PHE Potent synthetic opioids implicated in increase in drug overdoses National Patient Safety Alert - Public Health England 18-Aug-2021 Issued
SDA/2021/009 Glipizide (Minodiab) 5mg tablets - Supply disruption DHSC & NHS England and Improvement: Supply disruption alert 02-Aug-2021 Issued
SDA/2021/008 Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500 units in 0.45ml pre-filled syringes ... DHSC & NHS England and Improvement: Supply disruption alert 29-Jul-2021 Issued
12345678910...


* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert can be found in this update.

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency